FTC sues major pharmacy advantage supervisors over insulin prices The agency brought action versus Caremark, Specific Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating methods “artificially inflated” the list cost of lifestyle-preserving insulin medication. Elevance lowers advice on ‘unparalleled’ Medicaid troubles Executives stated the improved expenditures pr... https://arizonahardteanutritionfa26150.full-design.com/the-smart-trick-of-healthcare-news-that-nobody-is-discussing-73279768